MergerLinks Header Logo

Submit Deal

Submit Deal

Cover Image Daniel Skovronsky
Daniel SkovronskyELI LILLY AND COMPANY

Daniel Skovronsky

Chief Scientific and Medical Officer and President of Research Laboratories at ELI LILLY AND COMPANY

Manager

Deal Bio

Total Deals3
Valued Deals3
Total Value£ 9.32 B
Avg. Deal Size£ 3.11 B

Market Context

Sort

07 Jan 2019|United States|Biotechnology
Loxo Oncology
Eli Lilly And Company

Target: LOXO ONCOLOGY INC

Bidder: ELI LILLY AND COMPANY

6 Service Providers

3 Target | 3 Bidder

55 Dealmakers

33 Target | 22 Bidder

£ 6.28 B

Value

18 Oct 2022|United States|Pharmaceuticals
AKOUOS
Eli Lilly And Company

Target: AKOUOS

Bidder: ELI LILLY AND COMPANY

7 Service Providers

5 Target | 2 Bidder

22 Dealmakers

5 Target | 17 Bidder

£ 539 M

Value

08 Jul 2024|United States|Biotechnology
Morphic Holding
Eli Lilly And Company

Target: MORPHIC HOLDING INC

Bidder: ELI LILLY AND COMPANY

9 Service Providers

6 Target | 3 Bidder

53 Dealmakers

48 Target | 5 Bidder

£ 2.50 B

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2025 Datasite